Oncology/Hematology

Ovarian Cancer

More in Ovarian Cancer

Many With Cancer Predisposition Diseases Unaware of Genetic Status

Moreover, a significant proportion do not qualify for genetic screening under current guidelines

Apr 19, 2023
AACR over a photo of Orange County Convention Center in Orlando, Florida.
Risks Outweigh Benefits for BSO at Benign Hysterectomy in Younger Women

It's less clear-cut for postmenopausal women, study authors say

Apr 18, 2023
A computer rendering of a hysterectomy
Precancerous Lesions in Donor Organs; Dire Cancer Drug Shortage; CVD Ups Cancer Risk

News, features, and commentary about cancer-related issues

Apr 14, 2023
Onco Break over a computer rendering of a cancer cell.
VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy

Prospective study in heavily treated population is warranted, researcher says

Mar 30, 2023
SGO over a photo of the Tampa Convention Center in Tampa, Florida
Novel Strategies Show Winning Potential in Ovarian Cancer

High response rates in small studies of immuno-oncology combination, neoadjuvant olaparib

Mar 28, 2023
SGO over a photo of the Tampa Convention Center in Tampa, Florida
CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer

Responses in a fourth of patients, clinical benefit in up to 90%

Mar 26, 2023
SGO over a photo of the Tampa Convention Center in Tampa, Florida
Cancer and Heart Disease; Screening During COVID; CBD for Smoking Cessation

News, features, and commentary about cancer-related issues

Feb 17, 2023
Onco Break over a computer rendering of a cancer cell.
Faking a Cancer Dx? Fallopian Tube Removal; Trodelvy's New Breast Cancer Indication

News, features, and commentary about cancer-related issues

Feb 03, 2023
Onco Break over a computer rendering of a cancer cell.
Uterine Cancer Recognized as 9/11-Related; Working With Cancer; Post-Dx Suicide Risk

News, features, and commentary about cancer-related issues

Jan 20, 2023
Onco Break over a computer rendering of a cancer cell.
Cancer Survivors Say No to HPV Vax; Costly Prostate Cancer; Acupressure Aids Sleep

News, features, and commentary about cancer-related issues

Dec 29, 2022
Onco Break over a computer rendering of a cancer cell.
OS Benefit Eludes Second-Line Niraparib Maintenance in Ovarian Cancer

Significant PFS results demonstrated in NORA trial don't extend to overall survival

Dec 17, 2022
A photo of a bottle of Zejula tablets over a computer rendering of ovarian cancer.
FDA OKs First Antibody-Drug Conjugate for Platinum-Resistant Ovarian Cancer

Mirvetuximab soravtansine produced responses in almost a third of patients in pivotal trial

Nov 15, 2022
FDA APPROVED mirvetuximab soravtansine (Elahere) over a computer rendering of ovarian cancer.
More Racial Cancer Disparities; Potential Pharma Bankruptcy; HPV Vax Efficacy

News, features, and commentary about cancer-related issues

Nov 10, 2022
Onco Break over a computer rendering of a cancer cell.
Pandemic Led to Surgical Delays in Gynecologic Cancers, and Worse Outcomes

One in five patients experienced changes in their care plan

Oct 04, 2022
IGCS over a photo of the Jacob K. Javits Convention Center in New York City
More in Ovarian Cancer

Continuing Medical Education

0.50 CME Credits
Optimizing Outcomes in Gastroesophageal Cancers: Expert Insights on Novel Biomarkers and Therapies

1.00 CME Credits
A Deep Dive on Novel and Emerging Evidence in the Treatment of HR+/HER2- Breast Cancer

1.00 CME Credits
Leveraging Expert-Informed Adverse Event Management and Supportive Care Strategies to Improve Patient Outcomes in Bladder Cancer

0.50 CME Credits
Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma

0.50 CME Credits
Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes

1.00 CME Credits
Expert Perspectives in Managing Lower-Risk Myelodysplastic Syndromes

1.00 CME Credits
Incorporating Recent Data Into Current Treatment Paradigms in Melanoma

0.50 CME Credits
Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers